Solex Energy Ltd Q1 FY2027 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/we7u1a0vax5o14enx5iz2j7h.pdf

Key Takeaways


ALMM-2 Disruption & Order Book

Chetan Shah: "These are the timing shifts and not cancellations. We do not currently see any orders at risk and whether ALMM is extended at any stage or not, there is no impact on our order book because we are prepared for both scenarios."

Financial Performance & Cost Absorption

Vipul Shah: "If you see the Solex trajectory, the difference is 1:3, that is the huge gap and the way Solex has been performing."

Cell Supply & Domestic Manufacturing


Cell Line Project & Funding

Chetan Shah: "These are the two major factors where we are taking little bit more time than what it was expected. But I think we are on track and our preparation and homework is such that we will ensure that whatever that time we have consumed on this phase, we will overcome in terms of the execution because almost everything is designed, the agencies, everything is aligned."

Order Pipeline & Revenue Visibility

Chetan Shah: "Renewable energy, particularly solar, is not a quarter-to-quarter business."

OEM, Exports & BESS Expansion

Vipul Shah: "We are not going to just jump in the BESS seeing the opportunity and everything, but whenever we do, it will be very calibrated manner."

Industry Context & Competitive Position

Chetan Shah: "I don't see any very big challenge in terms of survival for the standalone module manufacturer because the market, the way the market is growing and then the captive market is also growing so fast..."

Guidance & Commitments

CommitmentSpecificsTimeline
Executable order pipeline₹845.84 crore targeted for executionBy December 31, 2026
Confirmed POs₹800 to 900 crore to be executedBy December 2026
FY27 revenue guidanceManagement remains aligned with FY27 revenue guidanceFY27
FY27 PAT margin5% to 6% rangeFY27
FY27 utilization assumptionAround 55% across the yearFY27
Cell line announcementTime schedule and partners to be disclosedOnce finance closure and electricity connection confirmation are done
DCR cell visibilityClear visibility for domestically available cellsLast quarter of FY27
DCR cell supply sufficiency~2.5 GW of G12R cells per annum from MOU partnersNext year (FY28)
OEM contract manufacturing decisionEvaluate if complete available capacity closes with domestic ordersQ4 FY27
EPC revenue target₹100 to 150 croreFY27
Grid stability resolutionConnectivity challenges to resolveIn a few months
Distribution channel entryGive thought to distribution once cell line is up and runningPost-2028

Key Metrics

MetricQ1 FY27
Revenue₹265.6 crore, +1.8% YoY vs ₹261 crore in Q1 FY26
EBITDA₹33.8 crore, vs ₹42.7 crore in Q1 FY26
EBITDA margin12.7%, vs 16.4% in Q1 FY26
Depreciation and amortization₹10.2 crore, vs ₹4.3 crore in Q1 FY26, full quarter impact of Line 3 and Line 4
Finance cost₹12.5 crore, vs ₹5.4 crore in Q1 FY26, higher working capital deployment
Profit before tax₹11.1 crore
PAT₹8.3 crore
PAT margin3.1%
Earnings per share₹7.39
FY27 PAT margin guidance5% to 6%
Order book visibilityapproximately ₹3,400 crore, across confirmed POs, signed MSAs, and MSAs at advanced discussion stage
Executable order pipeline by Dec 31, 2026₹845.84 crore, includes ₹628+ crore July order, ₹42.47 crore August order, and ₹175 crore LOI
FY27 average utilization assumptionaround 55% across the year
Module manufacturing capacity4 GW at Tadkeshwar, Gujarat
EPC business target₹100 crore to ₹150 crore, margin around 10% to 12%
Cell manufacturing project5 GW total, in two phases of 2.2 GW and 3 GW on a single site
BESS manufacturing expansion10 GW total, in two phases of 5+5
Shareholder base11,000+ shareholders